$15.87
0[0.00%]
Last update: 4:00PM Get Real Time Here
Kyverna Therapeutics
(NASDAQ:KYTX)Kyverna Therapeutics Stock (NASDAQ:KYTX), Quotes and News Summary
Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
| Open | $15.960 |
| Close | - |
| Volume / Avg. | 71.359K / 393.965K |
| Day Range | 15.240 - 16.320 |
| 52 Wk Range | 12.260 - 35.060 |
| Market Cap | $684.239M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 8.15% |
| Days to Cover | 4.14 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kyverna Therapeutics (KYTX) stock?
You can purchase shares of Kyverna Therapeutics (NASDAQ: KYTX) through any online brokerage.
Who are Kyverna Therapeutics's (KYTX) competitors?
Other companies in Kyverna Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Altimmune (NASDAQ:ALT).
What is the target price for Kyverna Therapeutics (KYTX) stock?
The latest price target for Kyverna Therapeutics (NASDAQ: KYTX) was reported by JP Morgan on Monday, March 4, 2024. The analyst firm set a price target for 39.00 expecting KYTX to rise to within 12 months (a possible 155.24% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kyverna Therapeutics (KYTX)?
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $15.28 last updated Today at May 16, 2024 at 1:13 PM EDT.
Does Kyverna Therapeutics (KYTX) pay a dividend?
There are no upcoming dividends for Kyverna Therapeutics.
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Kyverna Therapeutics (KYTX) going to split?
There is no upcoming split for Kyverna Therapeutics.
What sector and industry does Kyverna Therapeutics (KYTX) operate in?
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.